As used in this chapter:

1. 1. “Cannabidiol” means a nonpsychoactive cannabinoid found in the plant Cannabis sativa L. or Cannabis indica or any other preparation thereof that is essentially free from plant material, and has a tetrahydrocannabinol level of no more than three percent.
2. 2. “Department” means the department of public health.
3. 3. “Intractable epilepsy” means an epileptic seizure disorder for which standard medical treatment does not prevent or significantly ameliorate recurring, uncontrolled seizures or for which standard medical treatment results in harmful side effects.
4. 4. “Neurologist” means an allopathic or osteopathic physician board-certified in neurology in good standing and licensed under chapter 148.
5. 5. “Primary caregiver” means a person, at least eighteen years of age, who has been designated by a patient’s neurologist or by a person having custody of a patient, as being necessary to take responsibility for managing the well-being of the patient with respect to the medical use of cannabidiol pursuant to the provisions of this chapter.

For future repeal of this section effective July 1, 2017, see §124D.8

2014 Acts, ch 1125, §3; 2015 Acts, ch 29, §21

Referred to in §124.401, §124D.3